Navigation Links
Pharmac Blamed Of Depriving People of Lifesaving Drug

Two cardiologists accuse Pharmac of not properly funding the cholesterol lowering drugs to the new Zealanders. They published the report in the New Zealand medical //journal which they point out the shortsighted approach of the agency toward important drugs.

Cardiologists Dr Chris Ellis and Dr Harvey White said that the agency did not allocate funds for the statins for a period of 20 years.

Statins are drugs which help in the reduction of cholesterol levels and prevent heart problems such as heart attacks and strokes.

Pharmac's policies have limited the access of statins to the patients who were in dire need of the drug. This has increased the number of people suffering from heart problems due to inaccessibility of the drug. Hence the cardiologists accuse the agency of patient neglect and public deceit.

The statins are very efficient in lowering the cholesterol levels by about 58%. The initial clinical trails conducted during1986 is a proof for the efficiency of the drug. Despite of its efficiency the drug was not made widely available to patients in New Zealand until 1997. After which only statins which showed no mortality and low beneficial outcomes were funded by the agency.

The report by the cardiologist therefore blames Pharmac for misrepresenting scientific data, ignoring evidence based medicine and restricting access to medicine with the help of bureaucratic hurdles. This has resulted in more harm and premature death to New Zealanders.

National's Associate Health spokeswoman Jackie Blue said that the agency would have to alter its funding policy for the welfare of the people and also to attract more pharmaceutical companies.


'"/>




Page: 1

Related medicine news :

1. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
2. Pharmaceutical giant offers AIDS related antifungal drug free to 50 countries
3. Medicis Pharmaceutical company enters pediatric market
4. Pharmacies in for a dose of bitter medicine
5. Pharmacia may take 51.5 percent Abbott stake
6. Pharmaceutical companies are targeting patients
7. FDA approves Watson Pharmaceuticals Oxytrol patch
8. Pharmacist’s Role in Medication Error
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
11. Pharmaceutical industries grant for R&D to be monitored
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2017)... ... January 24, 2017 , ... “The Octagon of Spiritual Balances”: ... of Spiritual Balances” is the creation of published author, Pastor Bernard J. Weathers, pastor ... holds a bachelor degree in religious education and a master degree in theology. , ...
(Date:1/24/2017)... ... 23, 2017 , ... OSF Ventures, the corporate investment arm ... platform headquartered in Silicon Valley that connects startups to corporations and invests in ... three-year agreement to be a corporate sponsor of Plug and Play’s program for ...
(Date:1/24/2017)... ... January 23, 2017 , ... During the ... Carol Francis, Psychologist in the South Bay area , explained “Watching Women’s ... all people and by all people shines as a bright beacon of determination ...
(Date:1/23/2017)... , ... January 23, 2017 ... ... translation and localization services for life science companies, has achieved ISO 17100:2015 ... TÜV SÜD America. ISO 17100 is the globally recognized standard that establishes ...
(Date:1/23/2017)... ... January 23, 2017 , ... The Masters ... management and evaluation leaders with decades of experience who remain current practitioners in ... States healthcare system, there is a renewed demand for versatile, data-driven leadership.The American ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 2017 7D Surgical announced today that ... U.S. Food and Drug Administration (FDA) and a ... North American commercial launch of its innovative Machine-vision ... the 7D Surgical System.  The ... and machine vision algorithms to eliminate the long-standing ...
(Date:1/23/2017)... and Markets has announced the addition of the "Needle Free Drug ... report to their offering. ... Highlights: The report provides a detailed analysis ... Market forecasts till 2025, using estimated market values as the ... Regions and Countries Key developments and strategies observed in ...
(Date:1/23/2017)... Alberta , January 23, 2017 ... del riñón (r enal) y ... sola dosis de a pabetalone    ... hoy los resultados preliminares de un ensayo en fase ... con discapacidad de riñón (renal) severa. Los datos demostraron ...
Breaking Medicine Technology: